Back to Search
SUBHASH CHANDER, MD
MD
Body Imaging Physician
NPI: 1982731261IndividualAccepts Medicare
Specialties, Licenses & Credentials
Body Imaging PhysicianPrimary
Radiology — Body Imaging
Code: 2085B0100X
4301078870(MI)
Education
OTHER
Class of 1989
Research & Publications (20)
Diaphragmatic and crural FDG uptake in hyperventilating patients: a rare pattern important to recognize.
PMID 15069327·Clin Nucl Med·2004
5-case
Retroperitoneal malignant peripheral nerve sheath tumor: evaluation with serial FDG-PET.
PMID 15192465·Clin Nucl Med·2004
5-case
Small cell carcinoma of the parotid gland: evaluation with FDG PET imaging.
PMID 15249830·Clin Nucl Med·2004
8-other
American Burkitt's lymphoma of the head and neck: evaluation with serial FDG-PET.
PMID 15365443·Clin Nucl Med·2004
5-case
An FDG positron emission tomographic study in a case of gastrointestinal stromal tumor.
PMID 12642718·Clin Nucl Med·2003
5-case
High 2-deoxy-2-[18F]fluoro-D-glucose accumulation in a case of retroperitoneal fibrosis following resection of carcinoid tumor.
PMID 14537112·Mol Imaging Biol·2002
8-other
Using molecular markers to identify two major loci controlling carotenoid contents in maize grain.
PMID 17960357·Theor Appl Genet·2008
4-observational
Comparison of nutritional traits variability in selected eighty-seven inbreds from Chinese maize (Zea mays L.) germplasm.
PMID 18620402·J Agric Food Chem·2008
4-observational
Anticancer steroid sulfatase inhibitors: synthesis of a potent fluorinated second-generation agent, in vitro and in vivo activities, molecular modeling, and protein crystallography.
PMID 18723489·Mol Cancer Ther·2008
7-preclinical
Synthesis of aromatase inhibitors and dual aromatase steroid sulfatase inhibitors by linking an arylsulfamate motif to 4-(4H-1,2,4-triazol-4-ylamino)benzonitrile: SAR, crystal structures, in vitro and in vivo activities.
PMID 18816537·ChemMedChem·2008
8-other
The in vivo properties of STX243: a potent angiogenesis inhibitor in breast cancer.
PMID 18841154·Br J Cancer·2008
7-preclinical
Cyclin D1 (G870A) polymorphism and risk of cervix cancer: a case control study in north Indian population.
PMID 18548202·Mol Cell Biochem·2008
8-other
A new therapeutic strategy against hormone-dependent breast cancer: the preclinical development of a dual aromatase and sulfatase inhibitor.
PMID 18927286·Clin Cancer Res·2008
7-preclinical
Efficacy of three potent steroid sulfatase inhibitors: pre-clinical investigations for their use in the treatment of hormone-dependent breast cancer.
PMID 17914670·Breast Cancer Res Treat·2008
7-preclinical
17beta-hydroxysteroid dehydrogenase Type 1, and not Type 12, is a target for endocrine therapy of hormone-dependent breast cancer.
PMID 18183589·Int J Cancer·2008
7-preclinical
Identification of QTL for maize resistance to common smut by using recombinant inbred lines developed from the Chinese hybrid Yuyu22.
PMID 18436989·J Appl Genet·2008
8-other
Dual aromatase-sulfatase inhibitors based on the anastrozole template: synthesis, in vitro SAR, molecular modelling and in vivo activity.
PMID 17728860·Org Biomol Chem·2007
8-other
Dual aromatase-sulfatase inhibitors based on the anastrozole template: synthesis, in vitro SAR, molecular modelling and in vivo activity.
PMID 17972413·Org Biomol Chem·2007
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3990 JOHN R ST
DETROIT, MI 48201 - Phone
- (313) 745-8040
Quick Facts
- NPI
- 1982731261
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 37
- Publications
- 20
Are you this provider?
Claim Your Profile